Posted on Wednesday, February 12, 2014 at 1:53 pm CST
Global Market Direct's pharmaceuticals report, "Yakult Honsha Co., Ltd. - Product Pipeline Review - 2013" provides data on the Yakult Honsha Co., Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Wednesday, February 12, 2014 at 1:19 pm CST
Global Market Direct's pharmaceuticals report, "Spirogen Ltd. - Product Pipeline Review - 2013" provides data on the Spirogen Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Wednesday, February 12, 2014 at 1:18 pm CST
Global Markets Direct's, 'Cartilage Degeneration - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Cartilage Degeneration, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cartilage Degeneration. Cartilage Degeneration - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Wednesday, February 12, 2014 at 12:22 pm CST
Global Market Direct's pharmaceuticals report, "DesignMedix, Inc. - Product Pipeline Review - 2013" provides data on the DesignMedix, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Wednesday, February 12, 2014 at 11:53 am CST
Global Markets Direct's, 'Nonmelanomatous Skin Cancer - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Nonmelanomatous Skin Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Nonmelanomatous Skin Cancer. Nonmelanomatous Skin Cancer - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Wednesday, February 12, 2014 at 11:44 am CST
Global Market Direct's pharmaceuticals report, "Ache Laboratorios Farmaceuticos S/A - Product Pipeline Review - 2013" provides data on the Ache Laboratorios Farmaceuticos S/A's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Wednesday, February 12, 2014 at 11:17 am CST
Global Markets Direct's, 'Nephropathy - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Nephropathy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Nephropathy. Nephropathy - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Wednesday, February 12, 2014 at 9:29 am CST
Global Markets Direct's, 'Bacterial Conjunctivitis - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Bacterial Conjunctivitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bacterial Conjunctivitis. Bacterial Conjunctivitis - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Wednesday, February 12, 2014 at 4:00 am CST
The world recently found out that Former Jets quarterback Joe Namath, who led the team to its only Super Bowl championship has been living with the lifelong effects of his concussions sustained during his professional football career. Every time another pro football player makes headlines because of a severe concussion sustained on the playing field, renowned neurobiologist and researcher Dr. Adrian Harel is reminded of the urgent need for more effective protocols to treat traumatic brain injury (TBI). TBI is a serious problem, and sports-related TBI – particularly among professional athletes – has frequently been in the news in recent years.
Source: Medicortex
Posted on Tuesday, February 11, 2014 at 2:43 pm CST
Global Market Direct's pharmaceuticals report, "Lanthio Pharma B.V. - Product Pipeline Review - 2013" provides data on the Lanthio Pharma B.V.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 2:06 pm CST
Global Market Direct's pharmaceuticals report, "AmVac AG - Product Pipeline Review - 2013" provides data on the AmVac AG's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 1:44 pm CST
Global Market Direct's pharmaceuticals report, "XBiotech USA, Inc. - Product Pipeline Review - 2013" provides data on the XBiotech USA, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 1:35 pm CST
Global Market Direct's pharmaceuticals report, "Nuformix Ltd - Product Pipeline Review - 2013" provides data on the Nuformix Ltd's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 1:16 pm CST
Global Market Direct's pharmaceuticals report, "FirstString Research, Inc. - Product Pipeline Review - 2013" provides data on the FirstString Research, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 12:57 pm CST
Global Market Direct's pharmaceuticals report, "Nuron Biotech, Inc. - Product Pipeline Review - 2013" provides data on the Nuron Biotech, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 12:42 pm CST
Global Market Direct's pharmaceuticals report, "CureFAKtor Pharmaceuticals. LLC - Product Pipeline Review - 2013" provides data on the CureFAKtor Pharmaceuticals. LLC's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 11:58 am CST
Global Market Direct's pharmaceuticals report, "Armour Therapeutics Inc. - Product Pipeline Review - 2013" provides data on the Armour Therapeutics Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 11:39 am CST
Global Market Direct's pharmaceuticals report, "Kuhnil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013" provides data on the Kuhnil Pharmaceutical Co., Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 11:24 am CST
Global Market Direct's pharmaceuticals report, "Medinox, Inc. - Product Pipeline Review - 2013" provides data on the Medinox, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 11:17 am CST
Global Market Direct's pharmaceuticals report, "Concert Pharmaceuticals, Inc. - Product Pipeline Review - 2013" provides data on the Concert Pharmaceuticals, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 11:02 am CST
Global Market Direct's pharmaceuticals report, "EyeGate Pharmaceuticals, Inc. - Product Pipeline Review - 2013" provides data on the EyeGate Pharmaceuticals, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 10:49 am CST
Global Market Direct's pharmaceuticals report, "PDC Biotech GmbH - Product Pipeline Review - 2013" provides data on the PDC Biotech GmbH's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 10:25 am CST
Ranirestat (Microvascular Complications of Diabetes) - Forecast and Market Analysis to 2022
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 9:52 am CST
Global Markets Direct's, 'Left Ventricular Dysfunction - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Left Ventricular Dysfunction, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Left Ventricular Dysfunction. Left Ventricular Dysfunction - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Tuesday, February 11, 2014 at 9:49 am CST
Global Market Direct's pharmaceuticals report, "Braasch Biotech LLC - Product Pipeline Review - 2013" provides data on the Braasch Biotech LLC's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research